MR Diffusion Weighted Imaging and TRUS Jointly Guided Transperineal Prostate Biopsy(Report of 90 Cases)

Dongya WANG,Wenbin DAI,Huadong MIAO,Jia ZHAN,Zhongquan SUN,Jianda SONG

DOI: https://doi.org/10.3969/j.issn.1001-1420.2010.07.001

2010-01-01

Journal of Clinical Urology

Abstract:Objective:To investigate the value of the new technology-magnetic resonance (MR) diffusion weighted imaging (MRDWI) in the diagnosis of prostate cancer (CaP);explore how to biopsy the MRDWI suspicious lesion guided by TURS; compare the diagnostic accuracy of prostate biopsy guided by combination of MRDWI and TRUS with only TRUS. Methods: Between April 2007 and Dec 2008, 90 patients (Average age 69,average PSA10. 9μg/L) with suspected prostate cancer underwent TRUS and MRDWI. Physicians from MRI、Ultrasound and urological division study the imaging together and consider the hypo echo or low apparent diffusion coefficient on MRDWI as suspected lesion. Prostate biopsy protocol is suspected lesion directed biopsy plus ten cores systematic biopsy. Management of TRUS guided biopsy the suspected lesion on MRDWI: 1. locate the lesion in detail on MRDWI (measure the distance from central of lesion to bladder neck as L, to centerline of prostate as X, to dorsal margin of prostate as H). 2 pull back cross-section probe by length of L from bladder neck to locate the lesion site on TRUS, define the core of lesion on the cross-section image according to X and H. measure the diagonal distance from core of lesion to probe as O. 3 get to the lesion site correctly in real time by puncturing parallelly O higher than the probe plane on the longitudinal section including the core of lesion. Biopsy specimens are sent to pathological examination separately with defined puncture site. At last, record diagnostic result on MRDWI or TRUS and histological findings of every specimen. Results:Received a total of 963 prostate biopsy specimens, there are 171 cases of positive specimens and 123 cases of positive MRDWI, the sensitivity is 71. 9%(123/171),positive predictive value is(PPV) 54.7%(123/225); positive B ultrasound 39 cases,TRUS is 22. 8%(39/171)and PPV 56. 5% (39/69) respectively; among 792 negative specimens ,negative MRDWI results are 690,the specificity is 87. 1% (690/792), TRUS is 96. 2% (762/792) ; Among positive specimens , MRDWI + TRUS-result is 90(52.6%), TRUS+MRDWI-result is 6 (3. 5%),both positive result is 33 (19. 3%),both negative result is 42(24. 6%). sensitivity of MRDWI and TRUS jointly guided biopsy is 75. 4% (129/171), increasing 52. 6% than TRUS alone. Conclusions:The initial result of diagnostic value of MRDWI on prostate cancer shows high accuracy,more sensitive than TRUS. The management of TRUS guided puncture the suspected lesion according to MRDWI is simple and reliable. MRDWI and TRUS jointly guided biopsy can increase the sensitivity of lesion directed biopsy, and systemic biopsy is still necessary now in spite of increased diagnostic accuracy of MRDWI.